Coloplast A/S (CLPBF) Stock Price, News & Analysis

Company Overview

Coloplast A/S is a Denmark‐based medical device company specializing in the development and manufacturing of products and services for people with intimate healthcare needs. Founded in 1957 by Aage Louis‐Hansen and Poul Mollgaard Jensen, the company set out to improve quality of life for patients requiring ostomy care, and has since expanded into multiple clinical areas. Coloplast is headquartered in Humlebæk, Denmark, and combines in‐house research and development with strategic partnerships to drive innovation in its core markets.

The company’s product portfolio is organized around four primary areas: ostomy care, continence care, wound and skin care, and interventional urology. In ostomy care, Coloplast offers pouches, barrier rings and accessory products designed for secure, long‐wearing solutions. Its continence care range includes catheters, drainage bags and skin protection items for individuals managing urinary or fecal incontinence. In wound and skin care, the firm provides advanced dressings, compression garments and negative pressure therapy systems, while its interventional urology division focuses on minimally invasive tools for the diagnosis and treatment of conditions affecting the urinary tract.

Coloplast operates through a network of subsidiaries in more than 40 countries and distributes products via third‐party partners in additional markets across Europe, North America, Asia‐Pacific, Latin America, the Middle East and Africa. The company’s global footprint is supported by local sales, marketing and clinical teams that work closely with healthcare professionals and patient organizations to tailor solutions to regional needs.

Throughout its history, Coloplast has maintained a commitment to user‐driven innovation, drawing on direct feedback from patients and clinicians. While the company’s leadership has evolved over time, its enduring focus remains on delivering products that address sensitive healthcare needs, improve patient comfort and uphold stringent quality standards.

Key Stats

• Today's Range: $85.95 to $86.23
• 50-Day Range: $84.45 to $98.58
• 52-Week Range: $84.45 to $132.48
• Volume: 2,675 shs
• Average Volume: 382 shs
• Market Capitalization: N/A
• P/E Ratio: 7.55
• Dividend Yield: 8.70%
• Price Target: N/A
• Consensus Rating: N/A

Coloplast A/S Stock Analysis - MarketRank™

Coloplast A/S scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Coloplast A/S.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Coloplast A/S is 7.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.15.

Price to Earnings Ratio vs. Sector

The P/E ratio of Coloplast A/S is 7.55, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 84.89.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Coloplast A/S has a short interest ratio ("days to cover") of 6675, which indicates bearish sentiment.

Change versus previous month

Short interest in Coloplast A/S has recently increased by 13.33%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Coloplast A/S pays a meaningful dividend of 1.54%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Coloplast A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Coloplast A/S is 65.69%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Coloplast A/S has a short interest ratio ("days to cover") of 6675, which indicates bearish sentiment.

Change versus previous month

Short interest in Coloplast A/S has recently increased by 13.33%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.48

News Sentiment

Coloplast A/S has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Coloplast A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Coloplast A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 15.14% of the stock of Coloplast A/S is held by institutions.

CLPBF Stock Analysis - Frequently Asked Questions

How have CLPBF shares performed this year?

Coloplast A/S's stock was trading at $108.2810 at the start of the year. Since then, CLPBF stock has decreased by 20.4% and is now trading at $86.23.

How do I buy shares of Coloplast A/S?

Shares of CLPBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/15/2025
• Next Earnings (Estimated): 11/04/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CLPBF
• CIK: 1294325
• Web: www.coloplast.com
• Phone: (454) 911-1111
• Fax: N/A
• Employees: 15,930
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 7.55
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A